- REPORT SUMMARY
- TABLE OF CONTENTS
-
For almost 50 years, the fractionation of human plasma has been the sole possible source of a wide range of therapeutic proteins--such as coagulation factors, anticoagulants, immunoglobulins, and albumin--essential to the treatment of serious congenital or acquired bleeding or immunological diseases. In the last 20 years, the application of recombinant technologies to mammalian cell cultures has made possible--although with some limitations in productivity, costs, and immunogenic risks-
The report details the trend, potential and market size of Recombinant Plasma Proteins market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Recombinant Plasma Proteinsmarket, defines the market attractiveness level of Recombinant Plasma Proteins market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Recombinant Plasma Proteins industry, describes the types of Recombinant Plasma Proteins market, the applications of major players and the market size, and deeply analyzes the current situation of the global Recombinant Plasma Proteins market and the development prospects and opportunities of Recombinant Plasma Proteins industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Recombinant Plasma Proteins market in Chapter 13.
By Player:
Company 1
Company 2
Company 3
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10
By Type:
Chinese Hamster Ovary (CHO) Cell Line
Baby Hamster Kidney (BHK) Cell Line
Human Embryonic Kidney (HEK) Cell Line
Others
By End-User:
Hemophilia A
Hemophilia B
Von Willebrand Disease
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Recombinant Plasma Proteins Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Recombinant Plasma Proteins Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Recombinant Plasma Proteins Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Recombinant Plasma Proteins Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Recombinant Plasma Proteins Market Analysis and Outlook to 2022
-
7.1 Global Recombinant Plasma Proteins Consumption (2017-2022)
-
7.2 United States Recombinant Plasma Proteins Consumption (2017-2022)
-
7.3 Europe Recombinant Plasma Proteins Consumption (2017-2022)
-
7.4 China Recombinant Plasma Proteins Consumption (2017-2022)
-
7.5 Japan Recombinant Plasma Proteins Consumption (2017-2022)
-
7.6 India Recombinant Plasma Proteins Consumption (2017-2022)
-
7.7 South Korea Recombinant Plasma Proteins Consumption (2017-2022)
8 Region and Country-wise Recombinant Plasma Proteins Market Analysis and Outlook to 2028
-
8.1 Global Recombinant Plasma Proteins Consumption Forecast (2022-2028)
-
8.2 United States Recombinant Plasma Proteins Consumption Forecast (2022-2028)
-
8.3 Europe Recombinant Plasma Proteins Consumption Forecast (2022-2028)
-
8.4 China Recombinant Plasma Proteins Consumption Forecast (2022-2028)
-
8.5 Japan Recombinant Plasma Proteins Consumption Forecast (2022-2028)
-
8.6 India Recombinant Plasma Proteins Consumption Forecast (2022-2028)
-
8.7 South Korea Recombinant Plasma Proteins Consumption Forecast (2022-2028)
9 Global Recombinant Plasma Proteins Market Outlook by Types and Applications to 2022
-
9.1 Global Recombinant Plasma Proteins Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Chinese Hamster Ovary (CHO) Cell Line Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Baby Hamster Kidney (BHK) Cell Line Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Human Embryonic Kidney (HEK) Cell Line Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Recombinant Plasma Proteins Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hemophilia A Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hemophilia B Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Von Willebrand Disease Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Recombinant Plasma Proteins Market Outlook by Types and Applications to 2028
-
10.1 Global Recombinant Plasma Proteins Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Chinese Hamster Ovary (CHO) Cell Line Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Baby Hamster Kidney (BHK) Cell Line Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Human Embryonic Kidney (HEK) Cell Line Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Recombinant Plasma Proteins Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hemophilia A Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hemophilia B Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Von Willebrand Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Recombinant Plasma Proteins Import and Export Analysis (Top 5 Countries)
-
11.1 Global Recombinant Plasma Proteins Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Recombinant Plasma Proteins Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Recombinant Plasma Proteins Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Recombinant Plasma Proteins Market Competitive Analysis
-
14.1 Company 1
-
14.1.1 Company 1 Company Details
-
14.1.2 Company 1 Recombinant Plasma Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Company 1 Recombinant Plasma Proteins Product and Service
-
14.2 Company 2
-
14.2.1 Company 2 Company Details
-
14.2.2 Company 2 Recombinant Plasma Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Company 2 Recombinant Plasma Proteins Product and Service
-
14.3 Company 3
-
14.3.1 Company 3 Company Details
-
14.3.2 Company 3 Recombinant Plasma Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Company 3 Recombinant Plasma Proteins Product and Service
-
14.4 Company 4
-
14.4.1 Company 4 Company Details
-
14.4.2 Company 4 Recombinant Plasma Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Company 4 Recombinant Plasma Proteins Product and Service
-
14.5 Company 5
-
14.5.1 Company 5 Company Details
-
14.5.2 Company 5 Recombinant Plasma Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Company 5 Recombinant Plasma Proteins Product and Service
-
14.6 Company 6
-
14.6.1 Company 6 Company Details
-
14.6.2 Company 6 Recombinant Plasma Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Company 6 Recombinant Plasma Proteins Product and Service
-
14.7 Company 7
-
14.7.1 Company 7 Company Details
-
14.7.2 Company 7 Recombinant Plasma Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Company 7 Recombinant Plasma Proteins Product and Service
-
14.8 Company 8
-
14.8.1 Company 8 Company Details
-
14.8.2 Company 8 Recombinant Plasma Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Company 8 Recombinant Plasma Proteins Product and Service
-
14.9 Company 9
-
14.9.1 Company 9 Company Details
-
14.9.2 Company 9 Recombinant Plasma Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Company 9 Recombinant Plasma Proteins Product and Service
-
14.10 Company 10
-
14.10.1 Company 10 Company Details
-
14.10.2 Company 10 Recombinant Plasma Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Company 10 Recombinant Plasma Proteins Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Recombinant Plasma Proteins
-
Figure Recombinant Plasma Proteins Picture
-
Table Global Recombinant Plasma Proteins Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Recombinant Plasma Proteins Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Recombinant Plasma Proteins Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Recombinant Plasma Proteins Consumption by Country (2017-2022)
-
Figure United States Recombinant Plasma Proteins Consumption and Growth Rate (2017-2022)
-
Table Europe Recombinant Plasma Proteins Consumption and Growth Rate (2017-2022)
-
Figure China Recombinant Plasma Proteins Consumption and Growth Rate (2017-2022)
-
Figure Japan Recombinant Plasma Proteins Consumption and Growth Rate (2017-2022)
-
Figure India Recombinant Plasma Proteins Consumption and Growth Rate (2017-2022)
-
Figure South Korea Recombinant Plasma Proteins Consumption and Growth Rate (2017-2022)
-
Figure Global Recombinant Plasma Proteins Consumption Forecast by Country (2022-2028)
-
Figure United States Recombinant Plasma Proteins Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Recombinant Plasma Proteins Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Recombinant Plasma Proteins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Recombinant Plasma Proteins Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Recombinant Plasma Proteins Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Recombinant Plasma Proteins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chinese Hamster Ovary (CHO) Cell Line Consumption and Growth Rate (2017-2022)
-
Figure Global Baby Hamster Kidney (BHK) Cell Line Consumption and Growth Rate (2017-2022)
-
Figure Global Human Embryonic Kidney (HEK) Cell Line Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hemophilia A Consumption and Growth Rate (2017-2022)
-
Figure Global Hemophilia B Consumption and Growth Rate (2017-2022)
-
Figure Global Von Willebrand Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Chinese Hamster Ovary (CHO) Cell Line Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Baby Hamster Kidney (BHK) Cell Line Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Human Embryonic Kidney (HEK) Cell Line Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hemophilia A Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hemophilia B Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Von Willebrand Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Recombinant Plasma Proteins Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Recombinant Plasma Proteins Export by Region (Top 5 Countries) (2017-2028)
-
Table Company 1 (Foundation Year, Company Profile and etc.)
-
Table Company 1 Recombinant Plasma Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 1 Recombinant Plasma Proteins Product and Service
-
Table Company 2 (Foundation Year, Company Profile and etc.)
-
Table Company 2 Recombinant Plasma Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 2 Recombinant Plasma Proteins Product and Service
-
Table Company 3 (Foundation Year, Company Profile and etc.)
-
Table Company 3 Recombinant Plasma Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 3 Recombinant Plasma Proteins Product and Service
-
Table Company 4 (Foundation Year, Company Profile and etc.)
-
Table Company 4 Recombinant Plasma Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 4 Recombinant Plasma Proteins Product and Service
-
Table Company 5 (Foundation Year, Company Profile and etc.)
-
Table Company 5 Recombinant Plasma Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 5 Recombinant Plasma Proteins Product and Service
-
Table Company 6 (Foundation Year, Company Profile and etc.)
-
Table Company 6 Recombinant Plasma Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 6 Recombinant Plasma Proteins Product and Service
-
Table Company 7 (Foundation Year, Company Profile and etc.)
-
Table Company 7 Recombinant Plasma Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 7 Recombinant Plasma Proteins Product and Service
-
Table Company 8 (Foundation Year, Company Profile and etc.)
-
Table Company 8 Recombinant Plasma Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 8 Recombinant Plasma Proteins Product and Service
-
Table Company 9 (Foundation Year, Company Profile and etc.)
-
Table Company 9 Recombinant Plasma Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 9 Recombinant Plasma Proteins Product and Service
-
Table Company 10 (Foundation Year, Company Profile and etc.)
-
Table Company 10 Recombinant Plasma Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 10 Recombinant Plasma Proteins Product and Service
-